Celldex Therapeutics, Inc. — Director's Dealing 2013

Jul 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2013-07-01

Reporting Person: Marucci Anthony S (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-01	Common Stock	L	500	$5.95	Acquired	43368	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-01	Incentive Stock Option	$16.36	A	280000	Acquired	2023-07-01	Common Stock (280000)	Direct

Footnotes

F1: 25% vest on July 1, 2014 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.